Anti-Counterfeit Pharmaceutical Packaging Market size was over USD 148.34 billion in 2023 and is poised to reach USD 639.81 billion by the end of 2036, growing at around 11.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of anti-counterfeit pharmaceutical packaging is assessed at USD 162.46 billion.
This can be accounted to the increasing number of counterfeit products and growing demand for well-protected pharmaceutical drug packaging. According to the WHO, 1 out of every 10 medical products in developing countries is counterfeited or substandard. Amongst all the regions in the world, 42% of the reports came from Africa. Along with these, rising emphasis of manufacturers to safeguard their brand identities and stringent government regulations to prevent illegal drug channeling are also expected to drive growth to the market in the near future. Furthermore, development of innovative technologies for identification and authentication of medicines is estimated to provide impetus to the anti-counterfeit pharmaceutical packaging market in the coming years.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
11.9% |
|
Base Year Market Size (2023) |
USD 148.34 billion |
|
Forecast Year Market Size (2036) |
USD 639.81 billion |
|
Regional Scope |
|
The anti-counterfeit pharmaceutical packaging market can be segmented by technology into mass encoding, security printing & graphics, holograms, RFID, and security ink coatings. Out of these, the mass encoding segment is projected to hold a significant market share during the forecast period, owing to its excellent product tracking solution in several nodes of the supply chain management. However, the segment for RFID is estimated to register highest growth by the end of 2029, which can be attributed to the better tracking features and product security of this technology. Additionally, on the basis of feature, the segments for covert & overt features are evaluated to grow with a notable CAGR during the forecast period. This can be credited to the increasing adoption of covert & overt systems as they are able to offer authenticated packaging in the form of a visual representation or any other comprehensive method which is extremely hard to copy without a particular detection device.
Our in-depth analysis of the global market includes the following segments:
|
By Technology |
|
|
By Feature |
|
On the basis of regional analysis, the anti-counterfeit pharmaceutical packaging market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The North America industry is estimated to dominate majority revenue share by 2036, owing to rising focus on promoting the use of sustainable anti-counterfeit packaging alternatives and presence of the majority of key players. However, the Asia Pacific is calculated to record immense growth during the forecast period on the back of the growing realization among consumers that has led to them to become more aware regarding what they are buying before consumption, which in turn is also estimated to increase the demand of these packaging in this region. In addition, rising adoption of security technologies for medicines in China alone is also expected to drive anti-counterfeit pharmaceutical packaging market growth in the region.
March 2020: Avery Dennison Corporation, on March 2, 2020, announced that it has completely acquired Smartrac’s Transponder business for development and manufacture of RFID products, in a deal of around USD 226.58 million.
August 2020: CCL Healthcare joined hands with DoseID Consortium to expand its scope to the use of radio-frequency identification (RFID) technology in the healthcare sector.
Author Credits: Abhishek Anil
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?